Why This Marijuana Penny Stock Is Under the SEC’s Microscope Right Now

Growth Stock NetworkNovember 14, 2017Comments Off on Why This Marijuana Penny Stock Is Under the SEC’s Microscope Right Now

Marijuana stocks have delivered triple- and even quadruple-digit returns to investors in 2017. For example, Amfil Technologies Inc. (OTCMKTS: AMFE) has exploded a massive 1,942.8% so far this year.

But there’s still risk involved in this industry, as you’ll see when we detail this recent marijuana penny stock scandal. Afterward, we’ll also give you two important tips for avoiding these kinds of scams in the future.

This Marijuana Penny Stock Is Being Investigated by the SEC

The investigation involves one of 2013’s top-performing marijuana stocks: CV Sciences Inc. (OTCMKTS: CVSI), which also goes by the name CannaVest. It’s a Las Vegas-based cannabis firm charged with fraud back in June for falsifying its finances in 2013.

That year – 2013 – was considered a banner year for CVSI stock, which rocketed 700%, from $5 to $40. By January 2014, it had reached an all-time high of $70.

But CannaVest’s 700% return in 2013 has since been overshadowed by its crash in value. As of Nov. 10, the stock has plunged 99.7%, to $0.24, from that January 2014 peak.

Search The Mesh Report

Newsletter Sign-up

The Mesh Report delivered daily

Email

Sponsored

tastyworks, Inc. (“tastyworks”) has entered into a Market Agreement with Adam Mesh Trading (“Marketing Agent”) whereby tastyworks pays compensation to Marketing Agent to recommend tastyworks’ brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastyworks and/or any of its affiliated companies. Neither tastyworks nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastyworks does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website.